Puma Biotechnology (PBYI) Leases: 2019-2025
Historic Leases for Puma Biotechnology (PBYI) over the last 7 years, with Sep 2025 value amounting to $6.1 million.
- Puma Biotechnology's Leases rose 13.48% to $6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.1 million, marking a year-over-year increase of 13.48%. This contributed to the annual value of $4.6 million for FY2024, which is 41.23% down from last year.
- Per Puma Biotechnology's latest filing, its Leases stood at $6.1 million for Q3 2025, which was up 117.36% from $2.8 million recorded in Q2 2025.
- Puma Biotechnology's Leases' 5-year high stood at $15.8 million during Q1 2021, with a 5-year trough of $2.8 million in Q2 2025.
- Over the past 3 years, Puma Biotechnology's median Leases value was $6.2 million (recorded in 2024), while the average stood at $6.6 million.
- Examining YoY changes over the last 5 years, Puma Biotechnology's Leases showed a top increase of 13.48% in 2025 and a maximum decrease of 54.61% in 2025.
- Over the past 5 years, Puma Biotechnology's Leases (Quarterly) stood at $14.0 million in 2021, then decreased by 18.94% to $11.4 million in 2022, then plummeted by 31.42% to $7.8 million in 2023, then plummeted by 41.23% to $4.6 million in 2024, then climbed by 13.48% to $6.1 million in 2025.
- Its last three reported values are $6.1 million in Q3 2025, $2.8 million for Q2 2025, and $3.7 million during Q1 2025.